|
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended October 31, |
|
Nine Months Ended October 31, |
|
2021 |
2020 |
|
2021 |
2020 |
| Net loss per share - basic and diluted: |
|
|
|
|
|
| Numerator: |
|
|
|
|
Net loss attributable to Class A and
Class B common stockholders |
$ |
(29,231) |
|
$ |
(18,968) |
|
|
$ |
(77,175) |
|
$ |
(27,166) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
| Weighted-average shares outstanding used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted |
255,195 |
|
91,672 |
|
|
174,497 |
|
88,428 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per common share attributable to Class A and Class B common stockholders - basic and diluted |
$ |
(0.11) |
|
$ |
(0.21) |
|
|
$ |
(0.44) |
|
$ |
(0.31) |
|
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 |
|
|
|
| Convertible Preferred Stock |
— |
|
122,310 |
|
|
|
|
| Options to purchase common stock |
45,767 |
|
44,251 |
|
|
|
|
| Convertible note |
— |
|
8,294 |
|
|
|
|
| Performance share units |
3,175 |
|
— |
|
|
|
|
| Restricted stock units |
765 |
|
150 |
|
|
|
|
| ESPP |
293 |
|
— |
|
|
|
|
| Deferred stock compensation plan |
— |
|
759 |
|
|
|
|
| Warrants to purchase common stock |
2,500 |
|
2,731 |
|
|
|
|
| Total shares excluded from net (loss) income per share |
52,500 |
|
178,495 |
|
|
|
|
|